News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
866,505 Results
Type
Article (87723)
Company Profile (824)
Press Release (777939)
Multimedia
Podcasts (185)
Webinars (28)
Section
Business (233164)
Career Advice (4142)
Deals (39830)
Drug Delivery (144)
Drug Development (91345)
Employer Resources (203)
FDA (18344)
Job Trends (17414)
News (397674)
Policy (39946)
Tag
Academia (3006)
Academic (2)
Accelerated approval (24)
Adcomms (35)
Allergies (134)
Alliances (56980)
ALS (165)
Alzheimer's disease (1754)
Antibody-drug conjugate (ADC) (301)
Approvals (18429)
Artificial intelligence (576)
Autoimmune disease (127)
Automation (33)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (185)
Biotechnology (487)
Bladder cancer (149)
Brain cancer (60)
Breast cancer (585)
Cancer (4592)
Cardiovascular disease (404)
Career advice (3564)
Career pathing (39)
CAR-T (288)
CDC (59)
Cell therapy (779)
Cervical cancer (36)
Clinical research (76419)
Collaboration (1565)
Company closure (5)
Compensation (1051)
Complete response letters (64)
COVID-19 (2974)
CRISPR (93)
C-suite (724)
Cystic fibrosis (147)
Data (5701)
Decentralized trials (2)
Denatured (67)
Depression (131)
Diabetes (489)
Diagnostics (7160)
Digital health (42)
Diversity (12)
Diversity, equity & inclusion (49)
Drug discovery (266)
Drug pricing (206)
Drug shortages (36)
Duchenne muscular dystrophy (221)
Earnings (99870)
Editorial (59)
Employer branding (25)
Employer resources (173)
Events (134442)
Executive appointments (1009)
FDA (21145)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (7)
Frontotemporal dementia (21)
Funding (1416)
Gene editing (201)
Generative AI (59)
Gene therapy (614)
GLP-1 (1079)
Government (5416)
Grass and pollen (8)
Guidances (379)
Healthcare (20941)
HIV (54)
Huntington's disease (44)
IgA nephropathy (79)
Immunology and inflammation (270)
Immuno-oncology (33)
Indications (72)
Infectious disease (3241)
Inflammatory bowel disease (196)
Inflation Reduction Act (16)
Influenza (110)
Intellectual property (214)
Interviews (816)
IPO (17941)
IRA (59)
Job creations (5198)
Job search strategy (2866)
Kidney cancer (17)
Labor market (88)
Layoffs (651)
Leadership (38)
Legal (10153)
Liver cancer (94)
Longevity (14)
Lung cancer (640)
Lymphoma (356)
Machine learning (40)
Management (66)
Manufacturing (731)
MASH (164)
Medical device (14961)
Medtech (14999)
Mergers & acquisitions (22860)
Metabolic disorders (1272)
Multiple sclerosis (148)
NASH (23)
Neurodegenerative disease (319)
Neuropsychiatric disorders (85)
Neuroscience (2934)
NextGen: Class of 2025 (7703)
Non-profit (5102)
Now hiring (61)
Obesity (607)
Opinion (324)
Ovarian cancer (152)
Pain (183)
Pancreatic cancer (196)
Parkinson's disease (266)
Partnered (34)
Patents (462)
Patient recruitment (391)
Peanut (58)
People (66598)
Pharmaceutical (145)
Pharmacy benefit managers (30)
Phase I (23595)
Phase II (33173)
Phase III (24993)
Pipeline (3716)
Policy (317)
Postmarket research (3554)
Preclinical (10653)
Press Release (72)
Prostate cancer (226)
Psychedelics (52)
Radiopharmaceuticals (284)
Rare diseases (789)
Real estate (7435)
Recruiting (80)
Regulatory (28479)
Reports (65)
Research institute (2713)
Resumes & cover letters (651)
Rett syndrome (23)
RNA editing (16)
RSV (82)
Schizophrenia (147)
Series A (230)
Series B (175)
Service/supplier (30)
Sickle cell disease (99)
Special edition (26)
Spinal muscular atrophy (174)
Sponsored (46)
Startups (4324)
State (2)
Stomach cancer (19)
Supply chain (106)
Tariffs (97)
The Weekly (116)
Vaccines (1098)
Venture capital (76)
Weight loss (427)
Women's health (75)
Worklife (21)
Date
Today (142)
Last 7 days (686)
Last 30 days (2924)
Last 365 days (33434)
2025 (32041)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1288)
Alabama (84)
Alaska (7)
Arizona (324)
Arkansas (14)
Asia (51279)
Australia (9010)
California (10707)
Canada (3135)
China (1030)
Colorado (452)
Connecticut (478)
Delaware (320)
Europe (117890)
Florida (1572)
Georgia (346)
Hawaii (3)
Idaho (68)
Illinois (883)
India (62)
Indiana (516)
Iowa (22)
Japan (372)
Kansas (130)
Kentucky (41)
Louisiana (28)
Maine (81)
Maryland (1392)
Massachusetts (7947)
Michigan (339)
Minnesota (619)
Mississippi (6)
Missouri (132)
Montana (34)
Nebraska (27)
Nevada (117)
New Hampshire (81)
New Jersey (2934)
New Mexico (32)
New York (2868)
North Carolina (1524)
North Dakota (10)
Northern California (5030)
Ohio (324)
Oklahoma (22)
Oregon (52)
Pennsylvania (2176)
Puerto Rico (20)
Rhode Island (48)
South America (1656)
South Carolina (60)
South Dakota (1)
Southern California (4114)
Tennessee (165)
Texas (1675)
United States (39010)
Utah (323)
Vermont (1)
Virginia (270)
Washington D.C. (85)
Washington State (903)
West Virginia (4)
Wisconsin (111)
Wyoming (2)
There are 866,505 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Opus Genetics Announces Positive Recommendation from Independent Data Monitoring Committee for Phase 1/2 Trial in Best Disease
December 10, 2025
·
5 min read
Press Releases
Senti Bio Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for SENTI-202 in the Treatment of Adults with Relapsed or Refractory Acute Myeloid Leukemia
December 10, 2025
·
10 min read
Press Releases
Senti Bio Announces Updated SENTI-202 Clinical Data from Ongoing Phase 1 Trial in Relapsed or Refractory Acute Myeloid Leukemia Patients, Demonstrating Deep, MRD Negative, Durable Complete Remissions and a Favorable Safety Profile
December 10, 2025
·
14 min read
Press Releases
BioNTech and Bristol Myers Squibb Present First Global Phase 2 Data for PD-L1xVEGF-A Bispecific Antibody Pumitamig Showing Encouraging Efficacy in Advanced Triple-Negative Breast Cancer
December 10, 2025
·
15 min read
Press Releases
Fennec Pharmaceuticals Announces Investigator-Sponsored Trial to Be Conducted by City of Hope in Metastatic Testicular Germ Cell Tumors
December 10, 2025
·
12 min read
Press Releases
Transpire Bio Manufacturing Facility Receives the Establishment Inspection Report Following a Pre-Approval Inspection by the U.S. FDA
December 10, 2025
·
1 min read
Press Releases
Expert Melanoma Panel Recommends Castle Biosciences’ DecisionDx®-Melanoma as a Best-Practice Tool for Managing Patients with Melanoma
December 10, 2025
·
7 min read
Press Releases
Tonix Pharmaceuticals Appoints Irina Ishak as General Counsel
December 10, 2025
·
15 min read
Press Releases
Phanes Therapeutics to Present Phase 1/2 Study Results of Spevatamig (PT886) in Combination with Chemotherapy in Frontline (1L) Treatment of Metastatic PDAC at ASCO GI 2026
December 10, 2025
·
2 min read
Press Releases
Rapid Medical™ Completes Enrollment in DISTALS Trial Evaluating TIGERTRIEVER 13™ for Distal Vessel Occlusions
December 10, 2025
·
2 min read
1 of 86,651
Next
